Preclinical Imaging Market Size Worth $5.4 Billion by 2030: Grand View Research, Inc.

SAN FRANCISCO, April 19, 2022 /PRNewswire/ -- The global preclinical imaging market size is expected to reach USD 5.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.8% from 2022 to 2030. Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create additional demand for this market.

Key Insights & Findings from the report:

• By product, the optical segment accounted for the largest revenue share in 2021 owing to its wide usage in small animal imaging and new drug discovery projects.
• The multimodal imaging segment is expected to witness significant growth during the forecast period, owing to the technological advancements.
• North America accounted for the largest revenue share in 2021, well-developed research infrastructure, a large number of Preclinical projects, and higher adoption rates of technically advanced devices in the region are some of the factors that can be attributed to this share.
• Asia Pacific is anticipated to grow at a lucrative rate over the forecast period owing to the increased government funding for the development of the research and development sector.
• Major players in the industry are focusing on launch of advanced technology and features such as artificial intelligence enabled systems.

Read 120-page market research report, "Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (CT, MRI, PET/SPECT, Multi-modal, Optical, Ultrasound, Photoacoustic (PAT), Reagents, Services), By Region, And Segment Forecasts, 2022 - 2030", published by Grand View Research.

Preclinical Imaging Market Growth & Trends

Nuclear medicine techniques (primarily, positron emission tomography [PET] and single-photon emission computed tomography [SPECT]), optical imaging, micro computed tomography (CT), micro magnetic resonance imaging (MRI), Photoacoustic tomography (PAT) and ultrasound are the most suitable modalities for small-animal in vivo imaging applications. Each modality has its own set of benefits and drawbacks. The multimodality devices designed to give complementary information on the pathophysiological process under research have rapidly gained popularity, seeking to overcome the inherent limits of each imaging modality.

The combination of high-resolution modalities such as micro-CT and micro-MRI with highly sensitive techniques that provide functional information like micro-PET or micro-SPECT is expected to broaden the horizons of research in key areas like infection, oncology, cardiology, and neurology, contributing not only to the understanding of disease underlying mechanisms but also providing efficient and unique tools for evaluating new chemical entities and candidate drugs, thus boosting the market growth.

The market's prominent competitors are taking different initiatives such as funding's and acquisitions of medium and small-sized businesses in order to expand their product portfolio and enhance their manufacturing capacity. For instance, In November 2021, Bruker Corporation acquired MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging systems. This acquisition is expected to strengthen Bruker's position as a leading supplier in preclinical and translational imaging research.

Preclinical Imaging Market Segmentation

Grand View Research has segmented the global preclinical imaging market based on product and region:

Preclinical Imaging Product Outlook (Revenue, USD Million, 2018 - 2030)

• CT Imaging
• MRI Imaging
• PET/SPECT Imaging
• Multi-modal Imaging
• Optical Imaging
• Ultrasound Imaging
• Photoacoustic (PAT) Imaging
• Reagents
• Services

Preclinical Imaging Market - Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Asia Pacific
• Japan
• China
• India
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

List of Key Players of Preclinical Imaging Market

• Bruker Corporation
• Siemens A.G.
• General Electric (GE)
• TriFoil Imaging
• PerkinElmer, Inc.
• VisualSonics Inc. (Fujifilm)
• Mediso Ltd.
• Agilent Technologies
• MILabs B.V.
• MR Solutions
• Molecubes

Check out more related studies published by Grand View Research:

• Near Infrared Imaging Market - The global near infrared imaging market size is expected to reach USD 405.0 million by 2028, according to a new report by Grand View Research, Inc. expanding at a 9.3% CAGR during the forecast period.
• U.S. Imaging Services Market - The U.S. imaging services market size is expected to reach USD 192.1 billion by 2028, expanding at a CAGR of 7.3% from 2021 to 2028. Growing prevalence of various conditions, such as cancer and cardiac disorders, is expected to drive the market.
• Optical Imaging Systems Market - The global optical imaging systems market size is expected to reach USD 4.65 billion by 2030. It is expected to expand at a CAGR of 12.9% from 2022 to 2030. Technological advancements and a rise in the prevalence of ophthalmic disorders are anticipated to boost the growth of the market.

Browse through Grand View Research's Medical Devices Industry Research Reports.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Grand View Compass | Grand View Pipeline
Follow Us: LinkedIn | Twitter

SOURCE Grand View Research, Inc.